Search

everythinglearnresearchcommunity

for

Search:↓

The treatment was not recommended due to limited effectiveness and significant side effects.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Guselkumab effectively treats skin reactions caused by adalimumab in certain conditions.

Baricitinib is effective for severe alopecia areata but has some side effects.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Ebastine may help regrow hair in alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Dupilumab helped a 4-year-old grow hair back after another treatment failed.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

Leflunomide is more likely to help treat alopecia areata than cause it.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.